Sinusitis decisions — 2025

The Board remands the claim for service connection for rhinitis (including sinusitis and pharyngitis) to address whether it is due to asbestos exposure or other toxic exposure risk activity, and whether it is secondary to sarcoidosis.

The Board denied the veteran's claims for an increased rating for non-allergic rhinitis and a compensable rating for sinusitis, as the evidence did not support higher ratings based on the criteria provided.

The Board denied service connection for a psychiatric disability, lung disability, and heart disability. The claims for migraines/sinus headaches, allergic rhinitis, sinusitis, and sleep apnea were remanded for further development.

The Board remands the claims for service connection for asthma, bronchitis, obstructive sleep apnea, rhinitis, and sinusitis due to a pre-decisional duty to assist error.

The Board granted service connection for sinusitis and a separate disability rating of 10 percent for radiculopathy of the right leg, while denying a compensable rating for allergic rhinitis and a higher rating for degenerative arthritis of the spine.

The Board granted service connection for allergic rhinitis and denied service connection for left ear hearing loss, while dismissing the appeal for sinusitis. The claims for initial disability ratings for acute bronchitis and right knee osteoarthritis were remanded.

The Board granted an effective date of August 5, 2021 for service connection for allergic rhinitis and granted service connection for trapezius myositis and right knee arthritis.

The Board granted service connection for gastroesophageal reflux disease and chronic sinusitis, but denied it for obstructive sleep apnea.

The Board denied an evaluation higher than 30 percent for the service-connected irritable bowel syndrome with functional abdominal pain syndrome and remanded several other issues related to service connection.

The Board remands the claims for a nasal disability, to include allergic rhinitis, and left and right lower extremity peripheral neuropathy due to inadequate medical opinions.

The appeal concerning the issue of entitlement to a compensable disability rating for sinusitis is dismissed.

The Board granted service connection for rhinitis, bronchitis, and asthma based on presumed exposure to fine particulate matter or participation in TERA during service. The claim for an increased rating for chronic sinusitis was denied.

The Board granted service connection for chronic sinusitis, headaches as proximately due to the service-connected chronic sinusitis, posttraumatic stress disorder and major depressive disorder, and obstructive sleep apnea. The claims for edema and right ankle joint pain were denied.

The Board denied the veteran's claims for an initial compensable evaluation for sinusitis and irritable bowel syndrome (IBS), as well as a disability rating in excess of 10 percent for IBS prior to May 19, 2024.

The Board denied a compensable rating for allergic rhinitis and remanded the claim for service connection for sinusitis.

The Board granted service connection for chronic sinusitis, left hip bursitis, and bilateral plantar fasciitis. The claims for herpes, gastroesophageal reflux disease (GERD), a higher rating for shin splints, lumbosacral strain, and cervical/uterine polyps were denied.

The Board denied service connection for a headache disorder, rhinitis, thyroid nodule, left knee disability, and right knee disability as the evidence did not support a finding that these conditions were incurred in or aggravated by service.

The Board remands the claims for service connection and special monthly compensation due to inadequate medical opinions and failure to provide proper notice for scheduled examinations.

The Board denied service connection for a left knee disability, sinusitis, residuals of a left eye injury, dental injury to tooth 23, and hearing loss. The Veteran was granted an evaluation of 10 percent, but no greater, for a painful appendectomy scar.

The Board granted a 30 percent rating for benign paroxysmal positional vertigo (BPPV) prior to June 12, 2024, and denied all other claims including service connection for various respiratory conditions.